PHAT

MKT CAP:$737M

Phathom Pharmaceuticals Inc

Market Cap

$737M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$10.13-$5.58 (-35.52%)

Jun 5, 2026

52W High $18.0852W Low $7.83

Company Details

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the...

CEO

—

IPO Date

Oct 25, 2019

Website

www.phathompharma.com

Key Metrics TTM

Revenue

$205M

+150.3% YoY

Net Income

-$157M

EPS (Diluted)

Free Cash Flow

-$97M

Revenue / Share

$2.50

Gross Margin

84.9%

Operating Margin

-47.1%

Net Margin

-76.8%

FCF Margin

-47.5%

P/S

3.6x

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

Apr 30, 2026

$58M+104.4%

FY 2025

Feb 26, 2026

$175M+216.9%

Q4 2025

Feb 26, 2026

$58M+94.1%

Q3 2025

Oct 30, 2025

$50M+202.7%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee